• PHONE: (508) 545- 2190
  • info@hebecell.com
HebecellcorpHebecellcorp

CONSULTATION
  • About
  • Technology
    • Technology Overview
    • Functional iPS-NK Cells
    • Photoreceptor Precursor
    • Prevention/treatment
      of retinal Degeneration
  • News
  • Collaboration
  • Contact

Category Archives: News

Author By Jake HaoPosted on April 24, 2020October 20, 2020

HebeCell Corp Raises $10 million in Pre-Series A funding to Advance its NK Cell Development

HebeCell Corp (“HebeCell”) today announced that it has closed a US$10 million Pre-Series A financing to further advance the research and development of its leading patented scalable natural killer (NK) cell platform technology. Aceso Biotech Venture Fund invested in this round of financing.
Read More

Recent Posts

  • Proteintech and HebeCell Announce Collaboration on Nanobody iPSC-derived Natural Killer CellsNovember 11, 2020
  • Ankarys Therapeutics, Applied StemCell, and HebeCell Corp Announces Strategic Collaboration on iPSC-derived CAR-NK Cell TherapeuticsOctober 20, 2020
  • HebeCell Corp Raises $10 million in Pre-Series A funding to Advance its NK Cell DevelopmentApril 24, 2020
  • The Innate Killer Magazine 2020February 17, 2020
  • HebeCell will attend the Phacilitate Leaders World & World Stem Cell Summit 2020January 11, 2020

Our website

  • Home
  • About
  • Technology
  • Collaboration
  • Contact

Company

  • Careers
  • Privacy Policy

Contact us

21 Strathmore Rd, Natick,
MA, 01760, United States

+1 (508) 545- 2190
Info@hebecell.com

© HebeCell Corp. 2021 All right Reserved.
Website Design & Development by Noble House Media Group